Literature DB >> 29857920

Increased bone resorption in hemophilia.

E Carlos Rodriguez-Merchan1, Leonard A Valentino2.   

Abstract

In patients with hemophilia, osteoporosis is frequently observed for which the etiology remains unclear. The aim of this paper is to review the available experimental evidence indicating the presence of this disorder in patients with hemophilia, explore the potential mechanisms which may lead to reduced bone mineral density (BMD) and speculate on useful interventions to circumvent it. A narrative review of the English literature up to April 2018 was performed. The available evidence demonstrates an increased rate of bone resorption and an excess of osteoporosis among patients with hemophilia. FVIII and FIX may act through at least two pathways: promoting bone formation by a thrombin-mediated mitogenic effect on osteoblasts and by cytokine-mediated osteoclast activity. Another potential indirect mechanism mediated through the RANK-RANKL pathway has been suggested but remains controversial. The role of confounders such as lack of activity and immobility must be considered.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone resorption; Hemophilia; Osteoporosis

Mesh:

Substances:

Year:  2018        PMID: 29857920     DOI: 10.1016/j.blre.2018.05.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  12 in total

1.  Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project.

Authors:  Chiara Biasoli; Erminia Baldacci; Antonio Coppola; Raimondo De Cristofaro; Matteo N D Di Minno; Giuseppe Lassandro; Silvia Linari; Maria E Mancuso; Mariasanta Napolitano; Gianluigi Pasta; Angiola Rocino
Journal:  Blood Transfus       Date:  2021-10-15       Impact factor: 3.443

Review 2.  The role of orthopaedic surgery in haemophilia: current rationale, indications and results.

Authors:  E Carlos Rodríguez-Merchán
Journal:  EFORT Open Rev       Date:  2019-05-10

Review 3.  Hematological Diseases and Osteoporosis.

Authors:  Agostino Gaudio; Anastasia Xourafa; Rosario Rapisarda; Luca Zanoli; Salvatore Santo Signorelli; Pietro Castellino
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

4.  Incapacitating pain from Tenofovir Induced Hypophosphatemic Osteomalacia in a Hemophilia Patient - A Case Report.

Authors:  Emma Woo; Dinesh Kumbhare; Paul Winston
Journal:  Can J Pain       Date:  2020-12-14

5.  Role of tissue factor in delayed bone repair induced by diabetic state in mice.

Authors:  Hiroki Ehara; Kohei Tatsumi; Yoshimasa Takafuji; Naoyuki Kawao; Masayoshi Ishida; Kiyotaka Okada; Nigel Mackman; Hiroshi Kaji
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 6.  Low Bone Mineral Density in Hemophiliacs.

Authors:  Jennifer Gebetsberger; Michael Schirmer; Walter J Wurzer; Werner Streif
Journal:  Front Med (Lausanne)       Date:  2022-02-02

7.  Risk Factors for Amputation in the Surgical Treatment of Hemophilic Osteoarthropathy: A 20-Year Single-Center Report.

Authors:  Yiming Xu; Bin Feng; Wei Zhu; Yingjie Wang; Xisheng Weng
Journal:  Pain Res Manag       Date:  2022-03-28       Impact factor: 3.037

8.  Drug discovery in spinal cord injury-induced osteoporosis: a text mining-based study.

Authors:  Chenfeng Wang; Yang Xu; Lin Han; Weiqing Wu; Xuhua Lu
Journal:  Ann Transl Med       Date:  2022-07

9.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

Review 10.  Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A.

Authors:  Sandra Le Quellec
Journal:  Drug Des Devel Ther       Date:  2020-02-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.